Parkin (PD)
Asset
Promotes Parkin activity to clear dysfunctional mitochondria and protect dopaminergic neurons.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Parkinson's disease
Preclinical, ninesquaretx.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.